Early treatment response monitoring and cancer screening

Dr. Greg Czarnota, director of the Odette Cancer Research Program at SRI, is working to personalize treatment for women with breast cancer. He has invented a technology—Sonotype Dx—that blends artificial intelligence and ultrasound to let clinicians decide with high accuracy whether a woman will respond to standard chemotherapy or radiotherapy. If it’s determined these treatments won’t work, then other options can be explored. The test requires no surgery or invasive biopsy, is done during the woman’s first appointment and only takes a few minutes.